Skip to content

Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

Manuela Loureiro Ferreira, Katie E. de Luca, Jaimie D Steinmetz, Garland T Culbreth, Marita Cross, Jacek A Kopec, Paulo H. Ferreira, Fiona Blyth, Rachelle Buchbinder, Jan Hartvigsen, Aimin Wu, Saeid Safiri, Anthony D. Woolf, Professor Gary S. Collins, Kanyin Liane Ong, Amanda Elizabeth Smith, Jessica A Cruz, Kai Glenn Fukutaki, Semagn Mekonnen Abate, Mitra Abbasifard, Mohsen Abbasi‐Kangevari, Zeinab Abbasi-Kangevari, Ahmed Abdelalim, Aidin Abedi, Hassan Abidi, Qorinah Estiningtyas Sakilah Adnani, Ali Ahmadi, Rufus Akinyemi, Abayneh Tadesse Alamer, Adugnaw Zeleke Alem, Yousef Alimohamadi, Mansour Abdullah Alshehri, Hosam A. Alzahrani, Sohrab Amiri, Hubert Amu, Cătălina Liliana Andrei, Tudorel Andrei, Benny Antony, Jalal Arabloo, Judie Arulappan, Ashokan Arumugam, Tahira Ashraf, Seyyed Shamsadin Athari, Nefsu Awoke, Sina Azadnajafabad, Till Bärnighausen, Lope Hugo Barrero, Amadou Barrow, Akbar Barzegar, Lindsay Bearne, Isabela M. Benseñor, Alemshet Yirga Berhie, Bharti Bhandari, Vijayalakshmi S Bhojaraja, Ali Bijani, Belay Boda Abule Bodicha, Srinivasa Rao Bolla, Javier Brazo‐Sayavera, Andrew M. Briggs, Chao Cao, Periklis Charalampous, Vijay Kumar Chattu, Flavia Cicuttini, Benjamin Matthew Clarsen, Sarah Cuschieri, Omid Dadras, Xiaochen Dai, Lalit Dandona, Rakhi Dandona, Azizallah Dehghan, Takele Gezahegn Demie, Edgar Denova‐Gutiérrez, Syed Masudur Rahman Dewan, Samath Dhamminda Dharmaratne, Mandira Lamichhane Dhimal, Meghnath Dhimal, Daniel Díaz, Mojtaba Didehdar, Lankamo Ena Digesa, Mengistie Diress, Hoa Do, Linh Phuong Doan, Michael Ekholuenetale, Muhammed Elhadi, Sharareh Eskandarieh, Jawad Fares, Ali Fatehizadeh, Getahun Fetensa, Irina Filip, Florian Fischer, Richard Charles Franklin, Balasankar Ganesan, Belete Negese, Motuma Erena Getachew, Ahmad Ghashghaee

The Lancet Rheumatology · 2023 · 2,316 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Ferreira, M. L., Luca, K. E. de, Haile, L. M., Steinmetz, J. D., Culbreth, G. T., Cross, M., Kopec, J. A., Ferreira, P. H., Blyth, F., Buchbinder, R., Hartvigsen, J., Wu, A., Safiri, S., Woolf, A. D., Collins, P. G. S., Ong, K. L., Vollset, S. E., Smith, A. E., Cruz, J. A., … Ghashghaee, A. (2023). Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the global burden of disease study 2021. The Lancet Rheumatology, 5(6), e316-e329. https://doi.org/10.1016/s2665-9913(23)00098-x

In text: (Ferreira et al., 2023)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

Background: Low back pain is highly prevalent and the main cause of years lived with disability (YLDs). We present the most up-to-date global, regional, and national data on prevalence and YLDs for low back pain from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021. Methods: Population-based studies from 1980 to 2019 identified in a systematic review, international surveys, US medical claims data, and dataset contributions by collaborators were used to estimate the prevalence and YLDs for low back pain from 1990 to 2020, for 204 countries and territories. Low back pain was defined as pain between the 12th ribs and the gluteal folds that lasted a day or more; input data using alternative definitions were adjusted in a network meta-regression analysis. Nested Bayesian meta-regression models were used to estimate prevalence and YLDs by age, sex, year, and location. Prevalence was projected to 2050 by running a regression on prevalence rates using Socio-demographic Index as a predictor, then multiplying them by projected population estimates. Findings: In 2020, low back pain affected 619 million (95% uncertainty interval 554-694) people globally, with a projection of 843 million (759-933) prevalent cases by 2050. In 2020, the global age-standardised rate of YLDs was 832 per 100 000 (578-1070). Between 1990 and 2020, age-standardised rates of prevalence and YLDs decreased by 10·4% (10·9-10·0) and 10·5% (11·1-10·0), respectively. A total of 38·8% (28·7-47·0) of YLDs were attributed to occupational factors, smoking, and high BMI. Interpretation: Low back pain remains the leading cause of YLDs globally, and in 2020, there were more than half a billion prevalent cases of low back pain worldwide. While age-standardised rates have decreased modestly over the past three decades, it is projected that globally in 2050, more than 800 million people will have low back pain. Challenges persist in obtaining primary country-level data on low back pain, and there is an urgent need for more high-quality, primary, country-level data on both prevalence and severity distributions to improve accuracy and monitor change. Funding: Bill and Melinda Gates Foundation.

  1. The MOS 36-ltem Short-Form Health Survey (SF-36)1992
  2. The Pain Catastrophizing Scale: Development and validation.1995
  3. The McGill Pain Questionnaire: Major properties and scoring methods1975
  4. Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee1986
  5. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis1995

Metadata from OpenAlex (CC0). Citations are generated from the published record.